QuiVad
My list

Home / Japan / Nxera Pharma Co.,Ltd.

Nxera Pharma Co.,Ltd.

Short position disclosed on November 2, 2026.

Follow

Evolution of the disclosed total

0%2%4%6%8%
Aug 22Sep 10Sep 29Oct 18
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Linden Capital L.P.2.25%newNovember 2, 2026
Goldman Sachs International0.87%newOctober 29, 2026

Follow by RSS

Get the moves on Nxera Pharma Co.,Ltd. by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

108 disclosures on record for this share.
DateFund% of capitalEnd of publication
September 11, 2026Barclays Capital Securities Ltd0.61%
September 10, 2026UBS AG0.68%
September 9, 2026UBS AG0.75%
September 9, 2026Barclays Capital Securities Ltd0.50%
September 8, 2026Barclays Capital Securities Ltd0.75%
September 8, 2026BNP Paribas Financial Markets SNC0.65%
September 7, 2026Barclays Capital Securities Ltd1.07%
September 7, 2026モルガン・スタンレーmufg証券株式会社0.81%
September 4, 2026モルガン・スタンレーmufg証券株式会社0.64%
September 2, 2026Barclays Capital Securities Ltd1.15%
September 2, 2026UBS AG0.68%
September 1, 2026Barclays Capital Securities Ltd1.22%
September 1, 2026モルガン・スタンレーmufg証券株式会社0.49%
August 31, 2026Barclays Capital Securities Ltd1.12%
August 31, 2026UBS AG0.76%
August 31, 2026BNP Paribas Financial Markets SNC0.59%
August 31, 2026モルガン・スタンレーmufg証券株式会社0.50%
August 31, 2026Goldman Sachs International0.39%
August 31, 2026Citigroup Global Markets Limited0.00%
August 28, 2026Citigroup Global Markets Limited1.34%
August 28, 2026Barclays Capital Securities Ltd1.09%
August 27, 2026Barclays Capital Securities Ltd1.10%
August 27, 2026モルガン・スタンレーmufg証券株式会社0.74%
August 26, 2026Citigroup Global Markets Limited1.26%
August 25, 2026モルガン・スタンレーmufg証券株式会社0.65%
August 24, 2026Citigroup Global Markets Limited1.10%
August 21, 2026Citigroup Global Markets Limited1.52%
August 21, 2026Barclays Capital Securities Ltd1.00%
August 21, 2026Goldman Sachs International0.99%
August 21, 2026モルガン・スタンレーmufg証券株式会社0.76%
August 20, 2026Goldman Sachs International1.04%
August 19, 2026Citigroup Global Markets Limited1.30%
August 19, 2026Goldman Sachs International1.19%
August 19, 2026モルガン・スタンレーmufg証券株式会社0.87%
August 18, 2026Goldman Sachs International1.35%
August 18, 2026モルガン・スタンレーmufg証券株式会社1.06%
August 18, 2026Barclays Capital Securities Ltd0.96%
August 17, 2026Goldman Sachs International1.49%
August 17, 2026Barclays Capital Securities Ltd1.11%
August 14, 2026Citigroup Global Markets Limited1.20%
August 14, 2026モルガン・スタンレーmufg証券株式会社1.18%
August 14, 2026Barclays Capital Securities Ltd1.07%
August 14, 2026BNP Paribas Financial Markets SNC0.61%
August 13, 2026Goldman Sachs International1.54%
August 12, 2026Barclays Capital Securities Ltd1.15%
August 12, 2026UBS AG0.82%
August 10, 2026UBS AG0.79%
August 7, 2026Goldman Sachs International1.69%
August 7, 2026Citigroup Global Markets Limited1.11%
August 7, 2026Barclays Capital Securities Ltd1.09%

Download 108 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Japan

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Nxera Pharma Co.,Ltd., source JPX, data as at November 2, 2026, https://www.quivad.com/action/nxera-pharma-co-ltd?page=2